Memory disorders
Current Care Summary |  Published: 2017-03-13  
Working group appointed by the Finnish Medical Society Duodecim, Societas Gerontologica Fennica, Finnish Geriatricians, the Finnish Neurological Society, Finnish Psychogeriatric Association and the Finnish Association for General Practice
Print

Memory disorders

Current Care Summary
13.3.2017
Working group appointed by the Finnish Medical Society Duodecim, Societas Gerontologica Fennica, Finnish Geriatricians, the Finnish Neurological Society, Finnish Psychogeriatric Association and the Finnish Association for General Practice

Current Care Guideline «Muistisairaudet»1 and Summary «Muistisairaudet»2 in Finnish

Any complaint about memory should be examined. Diagnosis is based on international criteria. Basic evaluation consists of medical history, clinical evaluation, cognitive tests and brain imaging. When a diagnosis of Alzheimer's disease (AD), AD with cerebrovascular disease or with Lewy Body disease (LBD), or Dementia associated with Parkinson's disease or LBD is made, evidence-based medical therapy (acetylcholine esterase inhibitor or memantine) is indicated as a part of comprehensive care. In frontotemporal degenerations, these drugs are ineffective. For severe behavioural disorders, other psychoactive medications can be applied if non-pharmacological treatments are not sufficient.

Juha Rinne (Chair)

Ari Rosenvall

Timo Erkinjuntti

Hannu Koponen

Minna Löppönen

Minna Raivio

Timo Strandberg

Ritva Vanninen

Risto Vataja

Arja Tuunainen

Current Care Guidelines are independent, evidence-based clinical practice guidelines. These national guidelines cover important issues related to Finnish health, medical treatment as well as prevention of diseases. Learn more